Top Markets
Coin of the day
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.

BioDelivery Sciences International, Inc.

BDSI
Κατάταξη σε μετοχές #16145
BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical... BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical firm dedicated to the advancement and commercialization of therapeutic products designed for long-term health conditions, serving markets both within the United States and internationally. The company's product offerings leverage its proprietary BioErodible MucoAdhesive drug delivery system—a slender, dissolving polymer film intended for application to the inner cheek—in addition to other drug administration methodologies. Its portfolio includes several key products: BELBUCA, a buprenorphine buccal film, is utilized for the ongoing management of persistent pain. Symproic functions as a peripherally acting mu-opioid receptor antagonist, specifically addressing opioid-induced constipation in adult patients suffering from chronic non-cancer pain. This also covers individuals whose chronic pain is a result of prior cancer or its treatment, provided they do not require frequent increases in opioid dosage. ELYXYB, an oral solution containing celecoxib, provides treatment for adult migraines, irrespective of the presence of an aura. ONSOLIS, a soluble fentanyl film administered buccally, is intended for the management of sudden, severe "breakthrough" pain experienced by cancer patients. Founded in 1997, BioDelivery Sciences International, Inc. is headquartered in Raleigh, North Carolina. As of March 18, 2022, the company operates as a subsidiary of Collegium Pharmaceutical, Inc.
Τιμή μετοχής
$5.59
Τελευταίος συγχρονισμός: 2022-03-31
Κεφαλαιοποίηση
$310.83M
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
0.00%
Χώρα
US
Εμπόριο BioDelivery Sciences International, Inc. (BDSI)

Κατηγορία

Η τιμή BDSI με την κεφαλαιοποίηση του Β
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
BDSI
$5.59
Κεφαλαιοποίηση αγοράς του BioDelivery Sciences International, Inc.(BDSI)
Κεφαλαιοποίηση: $310.83M
Μέχρι το September 2026, η BioDelivery Sciences International, Inc. έχει χρηματιστηριακή αξία $310.83M. Αυτό καθιστά τη BioDelivery Sciences International, Inc. την 16145th πιο πολύτιμη εταιρεία στον κόσμο βάσει της κεφαλαιοποίησης σύμφωνα με τα δεδομένα μας. Η χρηματιστηριακή κεφαλαιοποίηση είναι η συνολική αγοραία αξία των μετοχών μιας εισηγμένης εταιρείας και χρησιμοποιείται συνήθως για να προσδιοριστεί η αξία μιας εταιρείας.
Ιστορικό κεφαλαιοποίησης αγοράς της BioDelivery Sciences International, Inc. από 2002 έως 2026
BDSI σε σύγκριση με τα 5 πιο δημοφιλή stocks
Η τιμή για BDSI Το περιουσιακό στοιχείο B Η κεφαλαιοποίηση αγοράς του B Αποτελέσματα
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$94,589.29 $310.83M
$5.260T +1,692,016.05%
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$85,937.53 $310.83M
$4.779T +1,537,244.07%
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$72,237.43 $310.83M
$4.017T +1,292,161.67%
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$66,888.39 $310.83M
$3.719T +1,196,472.32%
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.
$49,172.81 $310.83M
$2.734T +879,556.70%